6.44
price up icon5.40%   0.33
 
loading
Precedente Chiudi:
$6.11
Aprire:
$6.47
Volume 24 ore:
109.36K
Relative Volume:
0.80
Capitalizzazione di mercato:
$4.32M
Reddito:
$49,300
Utile/perdita netta:
$-6.27M
Rapporto P/E:
-0.7085
EPS:
-9.09
Flusso di cassa netto:
$-5.38M
1 W Prestazione:
+4.89%
1M Prestazione:
-6.60%
6M Prestazione:
-13.09%
1 anno Prestazione:
+109.23%
Intervallo 1D:
Value
$6.15
$6.53
Intervallo di 1 settimana:
Value
$5.71
$6.76
Portata 52W:
Value
$0.7425
$562.68

Aclarion Inc Stock (ACON) Company Profile

Name
Nome
Aclarion Inc
Name
Telefono
833 275 2266
Name
Indirizzo
8181 ARISTA PLACE, BROOMFIELD
Name
Dipendente
6
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ACON's Discussions on Twitter

Confronta ACON con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
ACON
Aclarion Inc
6.44 4.10M 49,300 -6.27M -5.38M -9.09
Health Information Services icon
VEEV
Veeva Systems Inc
223.26 37.72B 3.08B 860.33M 1.35B 5.1463
Health Information Services icon
TEM
Tempus Ai Inc
70.61 13.14B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
96.79 8.32B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
43.85 8.31B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
BTSG
Brightspring Health Services Inc
36.54 6.47B 11.99B 24.18M 234.31M 0.2956

Aclarion Inc Borsa (ACON) Ultime notizie

pulisher
Dec 12, 2025

Growth Value: Can GCT Semiconductor Holding Inc stock weather global recessionJuly 2025 Trends & AI Powered Market Entry Ideas - moha.gov.vn

Dec 12, 2025
pulisher
Dec 10, 2025

What drives Aclarion Inc stock priceReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - earlytimes.in

Dec 10, 2025
pulisher
Dec 09, 2025

Aclarion shares move higher after Nociscan highlighted in spine surgery journal - MSN

Dec 09, 2025
pulisher
Dec 06, 2025

Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq

Dec 06, 2025
pulisher
Dec 05, 2025

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) - Orthopedics This Week

Dec 05, 2025
pulisher
Dec 05, 2025

Can Aclarion Inc. Equity Warrant stock maintain growth trajectory2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Aclarion Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Dec 05, 2025
pulisher
Dec 05, 2025

Will Aclarion Inc. stock deliver better than expected guidance2025 Performance Recap & AI Forecast Swing Trade Picks - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Aclarion’s Nociscan featured in special pain issue of spine journal By Investing.com - Investing.com Nigeria

Dec 05, 2025
pulisher
Dec 05, 2025

Is Aclarion Inc. (IT20) stock vulnerable to rate hikes2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

How Aclarion Inc. (IT20) stock gains from tech spendingMarket Performance Recap & Weekly Stock Performance Updates - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Why Aclarion Inc. (IT20) stock stays resilientJuly 2025 Decliners & Target Return Focused Picks - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How sustainable is Aclarion Inc. Equity Warrant stock dividend payout2025 Market Trends & Detailed Earnings Play Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication - Quiver Quantitative

Dec 04, 2025
pulisher
Dec 04, 2025

Aclarion stock rises after feature in special pain issue of spine journal By Investing.com - Investing.com South Africa

Dec 04, 2025
pulisher
Dec 04, 2025

Aclarion stock rises after feature in special pain issue of spine journal - Investing.com Canada

Dec 04, 2025
pulisher
Dec 04, 2025

Aclarion’s Nociscan featured in special pain issue of spine journal - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

Aclarion announces publication of Nociscan article in pain issue of IJSS - TipRanks

Dec 04, 2025
pulisher
Dec 04, 2025

Aclarion's Nociscan Featured in International Journal of Spine Surgery's Special Pain Issue, Highlighting Advances in Chronic Low Back Pain Diagnosis - Quiver Quantitative

Dec 04, 2025
pulisher
Dec 04, 2025

Aclarion (Nasdaq: ACON) Nociscan case study guides targeted spine surgery - Stock Titan

Dec 04, 2025
pulisher
Dec 04, 2025

Can Aclarion Inc. (IT20) stock sustain double digit ROEJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is Aclarion Inc. (IT20) stock suitable for passive index fundsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Aclarion Inc. (IT20) stock sustain uptrend momentumQuarterly Trade Report & Smart Swing Trading Techniques - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Aclarion Inc. stock remain a Wall Street favoriteIPO Watch & Target Return Focused Stock Picks - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Aug Intraday: Will QRAFT AI Enhanced U.S. Large Cap stock return to pre crash levelsJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ

Dec 03, 2025
pulisher
Dec 03, 2025

Will Aclarion Inc. Equity Warrant stock reach Wall Street targets2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How Aclarion Inc. stock performs in high volatility marketsTrade Exit Report & Advanced Swing Trade Entry Plans - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Aclarion Inc. (IT20) stock outperform energy sector in 20252025 Volatility Report & AI Powered Market Trend Analysis - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S - marketscreener.com

Dec 02, 2025
pulisher
Dec 02, 2025

Aclarion, Inc. (ACON) 15.7% in Intraday Trading: Appointment of Commercial Director Drives Interest - Stocks Telegraph

Dec 02, 2025
pulisher
Dec 02, 2025

Aclarion appoints Jason Brosniak as commercial director, Eastern U.S. - TipRanks

Dec 02, 2025
pulisher
Dec 02, 2025

Press Release: Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - 富途牛牛

Dec 02, 2025
pulisher
Dec 02, 2025

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - The Globe and Mail

Dec 02, 2025
pulisher
Dec 02, 2025

Is Aclarion's Debt-Free Position The Backbone Of Its Next Phase Of Expansion? - RTTNews

Dec 02, 2025
pulisher
Dec 01, 2025

2 innovative micro-cap stocks for 2026 - MSN

Dec 01, 2025
pulisher
Dec 01, 2025

2 innovative micro-cap stocks for 2026 | 2025-12-01 | Investing News - Stockhouse

Dec 01, 2025
pulisher
Nov 30, 2025

Is Aclarion Inc Equity Warrant a good long term investmentEarnings Forecast Updates & Affordable Growth Investments - earlytimes.in

Nov 30, 2025
pulisher
Nov 27, 2025

Momentum Shift: Why Aclarion Inc. stock appeals to dividend seekersQuarterly Risk Review & Precise Buy Zone Identification - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

Can Aclarion Inc. stock hit record highs againInflation Watch & Fast Moving Market Watchlists - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

What margin trends mean for Aclarion Inc. stockMarket Activity Summary & Free Long-Term Investment Growth Plans - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 24, 2025

Aclarion loss widens, but balance sheet remains strong - BizWest

Nov 24, 2025
pulisher
Nov 22, 2025

Is Aclarion Inc a good long term investmentLarge Cap Stability Picks & Access Our Free Weekly Investment Letter - earlytimes.in

Nov 22, 2025
pulisher
Nov 22, 2025

Critical Review: Aclarion (ACON) vs. The Competition - Defense World

Nov 22, 2025
pulisher
Nov 21, 2025

Aclarion Inc. (ACON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

Why Aclarion Inc. (IT20) stock stays on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Aclarion Inc. Equity Warrant stock trading near support levels2025 Volatility Report & Daily Profit Maximizing Tips - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Positive Outlook on Aclarion, Inc. Driven by Revenue Growth and Strategic Investments - TipRanks

Nov 21, 2025
pulisher
Nov 20, 2025

Ascendiant Capital Maintains Aclarion (ACON) Buy Recommendation - Nasdaq

Nov 20, 2025
pulisher
Nov 20, 2025

Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

Nov 20, 2025
pulisher
Nov 20, 2025

Aclarion (ACON) Sees Price Target Boost by Ascendiant Capital | - GuruFocus

Nov 20, 2025

Aclarion Inc Azioni (ACON) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$43.86
price up icon 1.32%
$26.48
price down icon 6.60%
$24.91
price up icon 0.36%
$49.70
price down icon 0.18%
health_information_services WAY
$32.65
price up icon 0.59%
$36.54
price up icon 1.78%
Capitalizzazione:     |  Volume (24 ore):